Skip to main content

GenoLogics, Illumina Ink Deal for Geneus LIMS

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenoLogics today announced that it and Illumina have signed a worldwide co-selling agreement for the Geneus LIMS software.

Under the agreement, Illumina will market a version of the software pre-configured for its next-generation sequencers and TruSeq sample preparation kits. The pre-configured version will allow researchers to accelerate implementations, track library preparation and instrument runs, and prepare basic reports in weeks instead of months.

GenoLogics' Geneus LIMS software is specifically designed for genomics and next-gen sequencing, allowing researchers to automate workflows and trace samples and projects across multiple instruments and applications within one centralized system, the Victoria, British Columbia-based company said.

Financial and other terms of the deal were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.